Name: IMDX Balance Sheet - Insight Molecular Diagnostics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

IMDX - Insight Molecular Diagnostics Inc.

USD | NASDAQ | Healthcare

IMDX Balance Sheet - Insight Molecular Diagnostics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013
Cash And Short Term Investments
Cash And Equivalents	11.6	8.6	9.4	20.0	32.9	7.1	22.1	8.0	7.6	10.2	8.0	0.3	0.1
Restricted Cash	0.7	0.0	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	11.6	8.6	9.4	20.0	32.9	7.1	22.1	8.0	7.6	10.2	8.0	0.3	0.1
Receivables
Accounts Receivable	1.1	1.6	0.5	2.0	1.4	0.2	-	-	-	-	-	-	-
Current Assets
Inventory	0.4	0.4	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	1.4
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	6.5	2.5	1.1	1.6	1.5	1.0	0.8	-	-
Accumulated Depreciation
Current Liabilities
Accounts Payable	2.5	1.6	1.0	1.3	1.8	0.4	0.5	0.2	0.2	0.4	0.3	-	-
Short Term Debt	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	1.9	-	-	-	-
Operating Lease Liabilities Non-Current	-
Common Equity
Common Stock	369.2	338.2	310.3	294.9	253.0	157.2	124.6	74.7	60.0	45.8	34.9	-	-
Additional Paid In Capital	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	1.9	-	-	-	-
Net debt	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	28.2	11.6	18.7	24.3	31.0	8.6	3.4	9.3	5.6	9.4	13.8	17.4	11.8	20.0	32.1

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.8	7.2	-	6.2	5.6	2.6	-	1.5	2.0	1.4	1.1	1.5	1.1	1.1	1.6	1.5	1.3	1.3	1.5	1.4	1.4	1.0	1.0	0.8	0.7
Accumulated Depreciation	10.5	9.7	8.9	8.2	7.4	7.7	7.1	6.6	6.1	6.2	5.8	5.3	6.2	4.2	4.1	3.6	3.1
Property,Plant & Equipment Net	8.9	9.3	5.8	6.4	6.8	6.0	6.2	5.6	5.4	4.7	5.1	7.4	4.7	8.7	9.2	8.7	7.6
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18.7	18.7	18.7	9.5	18.4
Intangible Assets	-	-	14.6	14.6	14.6	14.6	56.5	56.6	56.6	56.6	56.6	56.6	56.6	61.6	88.4	89.3	90.3
Operating Lease Right Of Use Assets	-	-	-	-	-	-	-	-	-	-	4.0	4.0	3.5	3.5	3.5	3.5
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	0.6	0.6	0.7	0.7	0.6	0.7	0.7	0.6	0.4	0.5	0.5	0.3	0.4	0.4	0.4	0.4	0.3
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	40.4	25.8	43.9	50.5	60.4	35.1	70.2	74.7	71.0	74.9	81.6	87.5	82.8	100.1	157.3	171.1	146.3

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	51.1	57.2	53.1	49.4	50.1	47.4	60.5	52.0	54.1	49.3	39.1	39.2	39.3	60.5	75.4	83.0

Common Equity
Common Stock	394.3	369.2	368.5	368.0	367.4	338.2	326.7	326.2	310.6	310.3	310.0	309.5	295.5	294.9	292.5	289.6	255.0	-	251.2	240.8	234.2	-	152.0	150.2	138.1	124.6	115.1	114.1	113.4	74.7	74.3	70.7	68.4	60.0	59.4	50.0	49.4	45.8	45.4	35.3
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(405.1)	(400.8)	(377.8)	(367.0)	(357.2)	(350.5)	(317.0)	(303.5)	(299.0)	(289.9)	(262.1)	(262.1)	(262.1)	(260.7)	(215.7)	(206.4)	(198.1)
Accumulated Other Comprehensive Income	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	(10.7)	(31.5)	(9.2)	1.1	10.2	(12.3)	9.7	22.7	11.6	20.5	36.1	43.6	37.9	34.3	76.9	83.2	57.0
Total Equity	(10.7)	(31.5)	(9.2)	1.1	10.2	(12.3)	9.7	22.7	11.6	20.5	36.1	43.6	37.9	34.3	76.9	83.2	57.0	-

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	18.5	3.2	13.7	20.2	26.6	4.5	(4.3)	2.8	(1.8)	3.1	8.9	13.3	6.2	13.4	23.7	35.2	10.7	-
Book Value	(10.7)	(31.5)	(9.2)	1.1	10.2	(12.3)	9.7	22.7	11.6	20.5	36.1	43.6	37.9	34.3	76.9	83.2	57.0	-
Tangible Book Value	-	-	(23.8)	(13.5)	(4.4)	(26.9)	(46.8)	(33.8)	(45.0)	(36.1)	(20.5)	(13.0)	(18.7)	(27.3)	(30.2)	(24.8)	(52.0)